TY - JOUR
T1 - Implant supported overdentures in Sjögren's disease patients
T2 - a multicentre prospective cohort study
AU - Maarse, Floor
AU - Fennis, Willem M M
AU - Twisk, Jos W R
AU - Korfage, Anke
AU - Santing, Hendrik J
AU - den Hartog, Laurens
AU - Muradin, Marvick S M
AU - Raghoebar, Gerry M
AU - Vissink, Arjan
AU - Brand, Henk S
AU - Jager, Derk Hendrik Jan
PY - 2023/12/1
Y1 - 2023/12/1
N2 - OBJECTIVES: To prospectively investigate patient-reported outcomes and clinical performance of implant supported overdentures in edentulous Sjögren's disease (SjD) patients compared to subjects without SjD.METHODS: 51 implants were placed in 12 patients with SjD and 50 implants in 12 non-SjD patients to support overdentures. Clinical performance, marginal bone-level changes, patient satisfaction and oral health related quality of life (OHRQoL) were assessed at 1 (T1), 6 (T6), 12 (T12) and 18 (T18) months after placement of the overdenture. Patient satisfaction, ability to chew and OHRQoL were assessed with validated questionnaires. Marginal bone-level changes were measured on standardised dental radiographs. Clinical parameters included implant and overdenture survival, plaque, bleeding and gingival indices, and probing depth.RESULTS: OHRQoL in patients with SjD improved significantly after placement of implant supported overdentures at all measuring moments compared to baseline (p<0.05). Nevertheless, ability to chew tough and hard food was significantly better for non-SjD patients at all timepoints after placement of an implant supported overdenture (p<0.05). Implant survival at T18 was 100% in the patients with SjD and 98% in the non-SS group. Mean marginal bone loss at T18 did not differ between patients with SjD and non-SS patients, 1.12±0.74 mm and 1.43±1.66 mm, respectively (p=0.58). Clinical performance was good with no differences between the groups for all outcome measures (p>0.05).CONCLUSIONS: Implant-supported overdentures have a positive effect on OHRQoL and dental implants can be successfully applied in edentulous patients with SjD with nearly similar outcomes as in non-SjD subjects.
AB - OBJECTIVES: To prospectively investigate patient-reported outcomes and clinical performance of implant supported overdentures in edentulous Sjögren's disease (SjD) patients compared to subjects without SjD.METHODS: 51 implants were placed in 12 patients with SjD and 50 implants in 12 non-SjD patients to support overdentures. Clinical performance, marginal bone-level changes, patient satisfaction and oral health related quality of life (OHRQoL) were assessed at 1 (T1), 6 (T6), 12 (T12) and 18 (T18) months after placement of the overdenture. Patient satisfaction, ability to chew and OHRQoL were assessed with validated questionnaires. Marginal bone-level changes were measured on standardised dental radiographs. Clinical parameters included implant and overdenture survival, plaque, bleeding and gingival indices, and probing depth.RESULTS: OHRQoL in patients with SjD improved significantly after placement of implant supported overdentures at all measuring moments compared to baseline (p<0.05). Nevertheless, ability to chew tough and hard food was significantly better for non-SjD patients at all timepoints after placement of an implant supported overdenture (p<0.05). Implant survival at T18 was 100% in the patients with SjD and 98% in the non-SS group. Mean marginal bone loss at T18 did not differ between patients with SjD and non-SS patients, 1.12±0.74 mm and 1.43±1.66 mm, respectively (p=0.58). Clinical performance was good with no differences between the groups for all outcome measures (p>0.05).CONCLUSIONS: Implant-supported overdentures have a positive effect on OHRQoL and dental implants can be successfully applied in edentulous patients with SjD with nearly similar outcomes as in non-SjD subjects.
KW - Dental Prosthesis, Implant-Supported
KW - Denture, Overlay
KW - Humans
KW - Patient Satisfaction
KW - Prospective Studies
KW - Quality of Life
UR - http://www.scopus.com/inward/record.url?scp=85181176459&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85181176459&partnerID=8YFLogxK
U2 - https://doi.org/10.55563/clinexprheumatol/cryfka
DO - https://doi.org/10.55563/clinexprheumatol/cryfka
M3 - Article
C2 - 38019170
SN - 0392-856X
VL - 41
SP - 2418
EP - 2427
JO - Clinical and experimental rheumatology
JF - Clinical and experimental rheumatology
IS - 12
ER -